The chart below shows where VVX has traded over the past year, with the 50-day and 200-day moving averages included. In afternoon trading on Friday, VVX shares are changing hands at $58.00/share ...
The launch is the next phase of Polycom's emerging mobile video strategy, which kicked off last fall with RealPresence Mobile for Apple, Motorola and Samsung tablets. Polycom in recent months has ...
V2X Upgraded to Buy: Here's What You Should Know V2X (NYSE: VVX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating ...
In this article, we are going to take a look at where V2X, Inc. (NYSE:VVX) stands against the other most undervalued defense stocks to buy according to analysts. As we approach 2025 and beyond ...
While it can be more difficult to get approved for certain premium cards with a credit score of 600 or below, solid credit card options are still available. We’ve done the research, and these ...
Book to Bill Ratio: Approximately one for the quarter. V2X Inc (NYSE:VVX) reported strong third quarter results with revenue of $1.08 billion, representing an 8% growth year over year. The company ...
My 600-lb Life Season 13 does not have an official release date, but it will likely be announced in the future. As of April ...
The firm increased its portfolio allocation in VVX by 27.36% over the last quarter. FSCRX - Fidelity Small Cap Discovery Fund holds 437K shares representing 1.40% ownership of the company.
Thank you for joining us for the V2X Third Quarter 2024 Earnings Conference Call and Webcast. Today's call is being recorded. My name is Dave, and I will be the operator for today's call. At this ...
On Tuesday, Truist Securities maintained its Buy rating on V2X, Inc. (NYSE:VVX) shares with a consistent price target of $68.00. The decision follows V2X's announcement of an increased midpoint ...
Shares of V2X (NYSE:VVX) gained over 3% in premarket trading on Friday as Baird initiated its coverage on the defense contractor with an Outperform rating and a $75 price target. "We see healthy ...